BA
ANGO icon

Boston Advisors’s AngioDynamics ANGO Stock Holding History

Boston Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.48M Buy
80,116
+30,336
+61% +$593K 0.08% 314
2019
Q2 		$980K Hold
49,780
– – 0.05% 360
2019
Q1 		$1.14M Sell
49,780
-105
-0.2% -$2.28K 0.06% 321
2018
Q4 		$1M Buy
49,885
+5,200
+12% +$108K 0.06% 310
2018
Q3 		$971K Sell
44,685
-1,005
-2% -$22.3K 0.04% 383
2018
Q2 		$1.02M Buy
+45,690
New +$934K 0.03% 374

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Boston Advisors's ANGO Position: Q3 2019 in Review

Boston Advisors increased its AngioDynamics (ANGO) stake by 61% in Q3 2019, buying an estimated $593K and bringing the position to 80,116 shares worth $1.48M. The position accounts for 0.08% of the portfolio, ranked #314.

Boston Advisors first reported a position in ANGO in Q2 2018 and has held it in 6 quarters since. 173 funds tracked by Wall St. Rank hold ANGO as of Q3 2019.

  • Boston Advisors held 80,116 shares of AngioDynamics worth $1.48M as of Q3 2019.
  • Boston Advisors bought 30,336 AngioDynamics shares in Q3 2019, an estimated $593K.
  • AngioDynamics made up 0.08% of Boston Advisors's portfolio in Q3 2019, its #314 holding.
  • Boston Advisors first reported a position in AngioDynamics in Q2 2018 and has held it in 6 quarters since.
  • 173 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.